مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

330
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

338
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

RUTHENIUM-106 PLAQUE RADIOTHERAPY FOR RETINAL VASOPROLIFERATIVE TUMORS

Pages

  31-35

Abstract

 Purpose: To evaluate the effect of radiation with RUTHENIUM-106 (Ru-106) plaques in the control of RETINAL VASOPROLIFERATIVE TUMORs.Methods: This study is a retrospective, interventional nonrandomized case series. Seven eyes of seven patients (four males and three females) with RETINAL VASOPROLIFERATIVE TUMORs were enrolled. The eyes were treated by Ru-106 plaques with mean apex dose of 39 Gy (range, 38-43 Gy) in low-dose (LD) group (four cases) and 79 Gy (range, 76-81 Gy) in high-dose (HD) group (three cases). Mean (±SD) follow-up duration was 18 (±8) months (range, six to 31 months) Main outcome measures were tumor thickness reduction and clinical and visual improvement.Results: Mean (±SD) preoperative logMAR visual acuity improved from 0.92 (±0.49) to 0.85 (±0.71) at the last follow-up (P=0.50). Significant exudative retinal detachments, which were presented before BRACHYTHERAPY in five patients (71.4%), completely reabsorbed following BRACHYTHERAPY. Radiation retinopathy was seen in three patients during the follow-up period. Tractional rhegmatogenous retinal detachment developed in one patient of LD group which was managed with pars plana vitrectomy and silicon oil tamponade.Conclusion: BRACHYTHERAPY with high-dose Ru-106 plaques is an effective treatment modality for RETINAL VASOPROLIFERATIVE TUMORs in terms of functional and anatomic results. Further investigations with enough sample sizes are suggested to identify the optimal apex dose.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    NASERIPOUR, MASOUD, NAZARI, HOSSEIN, BAKHTIARI, P., AHADIAN, A., & JABERI, R.. (2009). RUTHENIUM-106 PLAQUE RADIOTHERAPY FOR RETINAL VASOPROLIFERATIVE TUMORS. JOURNAL OF CURRENT OPHTHALMOLOGY, 21(2), 31-35. SID. https://sid.ir/paper/550904/en

    Vancouver: Copy

    NASERIPOUR MASOUD, NAZARI HOSSEIN, BAKHTIARI P., AHADIAN A., JABERI R.. RUTHENIUM-106 PLAQUE RADIOTHERAPY FOR RETINAL VASOPROLIFERATIVE TUMORS. JOURNAL OF CURRENT OPHTHALMOLOGY[Internet]. 2009;21(2):31-35. Available from: https://sid.ir/paper/550904/en

    IEEE: Copy

    MASOUD NASERIPOUR, HOSSEIN NAZARI, P. BAKHTIARI, A. AHADIAN, and R. JABERI, “RUTHENIUM-106 PLAQUE RADIOTHERAPY FOR RETINAL VASOPROLIFERATIVE TUMORS,” JOURNAL OF CURRENT OPHTHALMOLOGY, vol. 21, no. 2, pp. 31–35, 2009, [Online]. Available: https://sid.ir/paper/550904/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button